Image Credit: STAT News
STAT+: Pharmalittle: We’re reading about Merck eyeing a biotech, a Moderna Covid vaccine trial, and more
Merck held talks over a potential $3 billion acquisition of MoonLake Immunotherapeutics, as it seeks to replenish its drug pipeline